Capnography Equipment Market

The global Capnography Equipment Market is valued at USD 390.1 Million in 2024 and is projected to reach a value of USD 649.7 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 4.75% between 2025 and 2035.

Capnography Equipment plays a vital role in medical environments by measuring the concentration of carbon dioxide (CO2) in exhaled breath. It is essential during anesthesia to monitor ventilation, particularly in critical care units and emergency departments, to evaluate a patients respiratory condition. Additionally, capnography helps identify respiratory problems like airway obstruction, respiratory depression, and the effectiveness of cardiopulmonary resuscitation (CPR). With ongoing technological advancements, capnography devices are becoming more accurate, portable, and better integrated with other monitoring systems, expanding their use in a wide range of medical situations.

The growing prevalence of respiratory conditions, and support from government initiatives, technological advancements are expected to drive Capnography Equipment market growth during the forecast period. The increasing use of capnography for managing respiratory diseases, due to its high reliability and effectiveness, is projected to improve the clinical performance of these devices in patient monitoring. For example, in 2022, 4.6% of adults were diagnosed with COPD, emphysema, or chronic bronchitis at some point in their lives. Additionally, 4.2% of office-based physician visits had COPD documented in medical records, and approximately 791,000 emergency department visits were primarily due to COPD.

Key Highlights

• In 2024, based on the Product Type, the Capnography accessories & disposables category accounted for significant market share of 53.2%
• Based on the Technology, the Mainstream Capnography category accounted for significant market share of 65.5% in 2024
• By Application, Cardiac surgeries segment dominated the Capnography Equipment market in 2024 with significant market share of 39.5%
• In 2024, Hospitals segment held the largest share of 80.5% in the Capnography Equipment market.
• North America dominated the Capnography Equipment market with 35.2% market share in 2024
• Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period

{{bar_graph}}

Product Type Overview

​The product type segment is divided into capnometers and capnography accessories & disposables. The Capnography accessories & disposables segment held the largest share of 53.2% in the Capnography Equipment market.

Capnography accessories & disposables segment growth is attributed to the increasing adoption of Capnography Equipment, recommendations for its use in patient monitoring, medical reimbursements in developed countries, and the rising number of surgical procedures.

Technology Overview

​The Technology segment is divided into Mainstream Capnography, Side stream Capnography, Micro stream Capnography. The Mainstream Capnography segment held the dominant share in 2024, accounting for significant market share of 65.5%.

Mainstream capnography is favored for its ease of use and its accuracy in monitoring the breathing of intubated patients, which is expected to drive further growth in this segment over the study period.

Application Overview

​The Application segment is divided into Cardiac Care, Trauma and Emergency Care, Respiratory Monitoring, Other Applications. The Cardiac surgeries segment held the dominant share in 2024, accounting for significant market share of 39.5%.

Cardiac Care dominated the Capnography Equipment market due to the increasing regulatory recommendations for capnography use during cardiac surgeries and the growing number of cardiopulmonary procedures performed worldwide.

End User

The End User segment is divided into Hospitals, Ambulatory Surgery Centers and Home Care, Other end users. The Hospitals segment held the largest share of 80.5% in the Capnography Equipment market.

The growth of hospitals is driven by evolving guidelines for capnography use and the rising incidence of chronic disorders, which are expected to increase demand for Capnography Equipment in hospital settings. The growth of this segment can be attributed to its advanced patient monitoring capabilities, a higher number of available ventilation measurement systems, and greater adoption rates. The market is expected to expand further due to the increasing number of surgeries and the rising prevalence of lifestyle-related conditions, such as diabetes and respiratory diseases like asthma. Additionally, the advanced infrastructure in hospitals in developed countries is anticipated to support the segments growth. According to the American Hospital Association, in 2023, there were approximately 6,129 registered hospitals in the U.S., with nearly 919,649 staffed beds.

Regional Overview

In 2024, the North America captured 35.2% of the revenue share.

North America Capnography Equipment market is driven by rising incidence of respiratory diseases, unhealthy lifestyles and high stress levels. Furthermore, the introduction of new reimbursement models for respiratory and monitoring solutions, along with strict regulatory guidelines aimed at improving patient safety, medical efficacy, and clinical efficiency, is expected to boost demand for these devices. A 2020 survey by the American Psychological Association revealed that increased stress negatively impacted 49% of U.S. adults, leading to greater bodily tension in 21%.

U.S. Capnography Equipment Market

The U.S. dominated the North American Capnography Equipment market with largest share in 2024, driven by the growing prevalence of respiratory conditions like COPD, asthma, and sleep apnea, which increases the need for continuous respiratory monitoring. In 2023, the American Lung Association launched a research institute with a commitment to investing USD 25 million annually in lung disease research.

Europe Capnography Equipment Market

Europes Capnography Equipment market showed significant growth potential in 2024, as these devices are essential for confirming endotracheal tube placement and differentiating between successful and failed intubations. The rising prevalence of chronic diseases such as diabetes and cancer are fueling demand for efficient medication delivery systems, further supporting market expansion. According to the World Health Organization, Chronic Obstructive Pulmonary Disease (COPD) is the fifth leading cause of death in Europe, with smoking being the primary risk factor.

U.K. Capnography Equipment Market

The UK Capnography Equipment market is expected to experience rapid growth in the coming years, driven by the increasing use of these devices in emergency departments, critical care, and ambulatory settings. Their high sensitivity and specificity have made them a mandatory tool in the UK for confirming endotracheal tube placement and managing cardiac arrest.

Germany Capnography Equipment Market

Germanys Capnography Equipment market held a significant share in 2024, due to the large patient population suffering from conditions like sleep apnea, asthma, and COPD, which is expected to boost device usage in the country.

Asia Pacific Capnography Equipment Market

The Asia Pacific Capnography Equipment market is set for significant growth, driven by the rising demand for effective respiratory monitoring systems and the introduction of new products to treat respiratory diseases in countries like India and China. For example, in May 2022, Max Ventilator launched multipurpose non-invasive ventilators with built-in humidifiers in India.

Japan Capnography Equipment Market

Japan is expected to see rapid growth in its Capnography Equipment market in the coming years due to the widespread adoption of these devices across healthcare settings. The increasing number of surgical procedures in Japan is driving the demand for capnography devices, which are essential for patient monitoring during anesthesia and surgery.

China Capnography Equipment Market

Chinas Capnography Equipment market held a substantial share in 2023, owing to the rising incidence of cancer. According to a 2022 China Pulmonary Health survey, the incidence of spirometry-defined COPD among adults was 8.6%, affecting nearly 100 million people, further driving the demand for respiratory monitoring devices.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Key Trends

• Growing Demand for Portable and Point-of-Care Devices: The increasing need for mobile and easy-to-use capnography devices, particularly for emergency and critical care settings, is driving the demand for portable point-of-care solutions
• Technological Advancements: Companies are focusing on enhancing the accuracy, mobility, and functionality of capnography devices, integrating features like real-time monitoring, wireless connectivity, and user-friendly interfaces to improve patient care
• Integration with Telemedicine: The rise of telehealth and remote patient monitoring is boosting the adoption of capnography devices, as they enable healthcare providers to track patients' respiratory status in real-time from remote locations
• Focus on Non-invasive Monitoring: There is a growing trend towards non-invasive capnography devices that provide accurate and real-time data without the need for invasive procedures, improving patient comfort and reducing risk
• Increasing Awareness of Capnography’s Clinical Benefits: As clinical evidence supporting the role of capnography in improving patient outcomes in critical care and emergency situations becomes more widespread, its adoption is expected to rise

{{dialog}}

{{dashboard_image}}

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

Growth of Portable and Point-of-Care Capnography Devices

Healthcare professionals can identify potential respiratory issues, such as airway obstruction, hyperventilation, hypoventilation, or apnea, early on by using capnography to monitor ventilation. Real-time respiratory parameter measurement aids in treatment decisions and timely intervention during respiratory events. Traditionally used in cardiology surgeries under anesthesia, the demand for portable and point-of-care capnography devices is increasing, particularly in trauma and emergency settings. To meet this demand, companies are developing handheld devices that offer mobility and easy patient access, such as the Microcap Handheld Capnograph (Medtronic), Capnocheck II (Smiths Group), and EMMA Capnograph (Masimo).

Stringent and Complex Regulatory Approval for Capnography Devices
Stringent regulatory guidelines, especially in the US, are hindering the growth of the capnography devices market. The lengthy approval process, which can take three to seven years, applies to even minor changes in an existing device or customized products. While simple devices often gain FDA approval, complex devices must meet extensive FDA requirements, causing delays in market availability. Furthermore, varying global regulations, including those set by the FDA for 3D-printed devices, create additional hurdles. Despite guidelines supporting the use of capnography in emergency settings, its adoption remains inconsistent due to regulatory challenges.

Growth in Emerging Markets

Emerging markets such as India, China, Brazil, and Mexico offer substantial growth opportunities for Capnography Equipment due to factors like expanding patient populations, increasing lifestyle diseases, growing investments in healthcare, and the rise of medical tourism. These countries are expected to account for a significant share of global healthcare spending by 2023. The increasing number of minimally invasive surgeries, improved healthcare infrastructure, and expanding hospitals in these regions further fuel demand for capnography devices. Manufacturers are focusing on strategic partnerships and collaborations to expand their reach in these growing markets.

Lack of Awareness Among Healthcare Professionals

In many emerging and less-developed countries, healthcare professionals have limited awareness of capnographys clinical benefits in surgeries and postoperative monitoring. Despite guidelines supporting its use, clinical adoption remains low, even in developed nations like the UK, where studies have shown that a significant percentage of ICUs do not routinely use capnography. The lack of clinical evidence regarding the safety and efficacy of capnography across various applications contributes to its slow adoption. This limited awareness and evidence gap are expected to hinder optimal use and adoption of capnography devices among healthcare professionals.

Competitive Landscape

The Capnography Equipment market is characterized by the presence of several key players focusing on innovation and product diversification. Major companies like Medtronic, Smiths Group, Masimo, and Philips are leading the market with advanced capnography solutions, including portable and point-of-care devices, to cater to growing demand in critical care, emergency, and surgical settings. These companies are increasingly investing in research and development to enhance device mobility, accuracy, and ease of use. Additionally, partnerships, acquisitions, and collaborations, such as the one between Philips and Masimo, are helping companies expand their product offerings and strengthen their market positions. The market also sees the emergence of regional players aiming to capture local demand by offering cost-effective solutions and targeting untapped markets.

The key players in the global Capnography Equipment market include - Becton among others.

Recent Market Developments

Philips and Masimo Expand Partnership to Enhance Global Telehealth

• In January 2023, Koninklijke Philips N.V. and Masimo strengthened their partnership to advance global telehealth initiatives. By leveraging cutting-edge technologies and solutions, their goal is to enhance healthcare delivery for both patients and healthcare providers, focusing on expanding remote patient monitoring and telehealth services worldwide

ICU Medical Acquires Smiths Medical to Broaden Product Portfolio

• In January 2022, ICU Medical Inc. completed the acquisition of Smiths Medical from Smiths Group plc, thereby integrating a broad portfolio of products, including syringes, vascular access devices, ambulatory infusion systems, and vital care solutions

The global Capnography Equipment market can be categorized as Product Type, Technology, Application, End User and Region.